Drug · DIN 02458683
MAEVE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 16, 2022; first marketed December 16, 2022.
- Drug Identification Number (DIN)
- 02458683
- Company (DIN owner)
- Glenmark Pharmaceuticals Canada Inc.Concord, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Norethisterone G03AC01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NORETHINDRONE | 0.35 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 9, 2022: NOC 28365Supplement to an Abbreviated New Drug Submission (SANDS) · To update Brand Name, Product Labels and Product Monograph. Administrative: Product Name Change
- November 3, 2016: NOC 18623Abbreviated New Drug Submission (ANDS)